viTToria biotherapeutics

0 followers


Vittoria Biotherapeutics develops gene-edited cell therapies.  they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.

Industries

+1

Stage

Employees

Links

Org chart

Nicholas Siciliano
CEO, Co-Founder & Director

Nicholas Siciliano

Collapse
Rosemary Mazanet
Chief Medical Officer
Adam Snook
Head, Preclinical Development
Aditya Nimmagadda
Senior Director, CMC
Steven Yang
Director, Laboratory Operations
Lori Forrest
Senior Controller